Ned Sharpless, the acting commissioner of the U.S. Food and Drug Administration (FDA), intends to maintain the course set by the former commissioner, Scott Gottlieb.
That was the gist of a statement Sharpless gave several weeks ago to FDA staff and, so far, he seems to be sticking with the plan.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,